Jacqueline Garcia, MD, Dana-Farber Cancer Institute, Boston, MA, talks on some important questions and topics in the field of myelodysplastic syndromes (MDS), including the role of post-transplant maintenance therapy, improving conditioning strategies, understanding the efficacy of immune checkpoint inhibition in MDS, and finding a new safe and effective backbone therapy in higher-risk MDS. This interview took place at the Tenth Annual Meeting of the Society of Hematologic Oncology (SOHO) held in Houston, TX.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.